ScoreWhy is Spago Nanomedical AB ?
1
Flat results in Mar 25
- INTEREST(9M) At SEK 0.12 MM has Grown at inf%
- ROCE(HY) Lowest at -107.53%
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -12.55%, its profits have risen by 4.5%
3
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -12.55% returns in the last 1 year, the stock has also underperformed OMX Stockholm 30 in each of the last 3 annual periods
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Spago Nanomedical AB for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Spago Nanomedical AB
-12.55%
-0.71
138.36%
OMX Stockholm 30
8.01%
0.44
18.11%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
13.46%
EBIT Growth (5y)
-15.74%
EBIT to Interest (avg)
-38.27
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.04
Sales to Capital Employed (avg)
0.05
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
5.81
EV to EBIT
-2.47
EV to EBITDA
-2.49
EV to Capital Employed
89.42
EV to Sales
58.79
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-3615.50%
ROE (Latest)
-166.75%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend11What is working for the Company
OPERATING CASH FLOW(Y)
Highest at SEK -30.57 MM
RAW MATERIAL COST(Y)
Fallen by -1.97% (YoY
OPERATING PROFIT(Q)
Highest at SEK -8.35 MM
PRE-TAX PROFIT(Q)
Highest at SEK -7.43 MM
NET PROFIT(Q)
Highest at SEK -7.43 MM
EPS(Q)
Highest at SEK -0.02
-6What is not working for the Company
INTEREST(9M)
At SEK 0.12 MM has Grown at inf%
ROCE(HY)
Lowest at -107.53%
Here's what is working for Spago Nanomedical AB
Operating Cash Flow
Highest at SEK -30.57 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (SEK MM)
Operating Profit
Highest at SEK -8.35 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (SEK MM)
Pre-Tax Profit
Highest at SEK -7.43 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (SEK MM)
Net Profit
Highest at SEK -7.43 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (SEK MM)
EPS
Highest at SEK -0.02
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (SEK)
Raw Material Cost
Fallen by -1.97% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Spago Nanomedical AB
Interest
At SEK 0.12 MM has Grown at inf%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (SEK MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
